Insulet reworks debt terms as Insulet stock gains 3.36 percent
Published on 10/05/2026 at 16:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Insulet (ISIN US45784P1012) was trading at EUR 119.98 at Lang & Schwarz on October 5, 2026 at 4:31 p.m. CEST, up 3.36 percent versus the EUR 116.08 prior close. As Simply Wall St reported on October 4, 2026, the company reworked its credit agreement by exchanging USD 475.00 million of term loans and expanding its revolving credit facility to USD 750.00 million.
Debt terms improve financial flexibility
The revised facility remained fully undrawn, according to Simply Wall St. Lower interest margins could reduce financing costs, but the balance-sheet change does not remove the operating risks tied to customer retention and device quality.
The financing update arrives after a sharp market reset. Simply Wall St said Insulet stock was down 53.50 percent year to date in its October 4 report, while its fair-value narrative cited USD 171.91 against a USD 131.69 reference price.
Revenue growth remains the key test
Insulet reported USD 801.70 million of revenue in the second quarter of 2026, up 23.50 percent from the same quarter a year earlier, according to MarketBeat. The comparison gives investors a sharper operating benchmark than the stock move alone, because the Omnipod platform must sustain growth while the company manages retention and competitive pressure.
MarketBeat also reported a consensus Hold rating from 26 firms, including 13 buys, 11 holds and 2 sells, with an average 12-month target of USD 195.40. Those figures put the financing change in context: analysts still see potential value, but the rating mix shows that the path from revenue growth to a higher valuation remains contested.
November results set the next test
Insulet said on October 1, 2026, that it will report third-quarter 2026 results before the market opens on November 4, 2026, according to its investor release. The scheduled report will show whether the second-quarter growth rate is holding and whether management can translate the new debt terms into lower financing pressure.
At Lang & Schwarz, Insulet stock was trading at EUR 119.98 on October 5, 2026 at 4:31 p.m. CEST, versus the EUR 116.08 prior close on October 2, 2026. The further course of trading is shown by the continuously updated real-time quote of Insulet stock.
Insulet stock facts
- Company: Insulet Corporation
- ISIN: US45784P1012
- Ticker: PODD
- Primary exchange: NASDAQ
- Price Lang & Schwarz as of October 5, 2026, 4:31 p.m. CEST: EUR 119.98
- Change versus prior close: plus 3.36 percent
- Prior close Lang & Schwarz October 2, 2026: EUR 116.08
- Market capitalization: USD 9.3 billion (as of October 5, 2026)
- 52-week range: USD 126.40-354.88 (as of October 5, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Next earnings date: November 4, 2026
